JPRN-UMIN000005943
招募中
2 期
The efficacy of lafutidine on heartburn in patients with mild gastroesophageal reflux disease (GERD) - The efficacy of lafutidine on heartburn in patients with mild gastroesophageal reflux disease (GERD)
概览
- 阶段
- 2 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Mild gastroesophageal reflux disease
- 发起方
- Wakayama Medical University
- 入组人数
- 40
- 状态
- 招募中
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\) Patients with hypersensitivity for Lafutidine 2\) Patients with serious liver abnormality 3\) Patients who took gastric acid inhibitors such as proton pump inhibitor and H2 blocker within 1 week 4\) Patients who taking medicine which interfere with the study 5\) Patients with depression symptoms 6\) Patients considered inappropriate by the study investigator
结局指标
主要结局
未指定
相似试验
已完成
不适用
Early effects of oral administrations of lafutidine with mint oil on intragastric pHHealty male volumteerJPRN-UMIN000001864Gastroenterology Division, Yokohama City University Graduate School of Medicine10
尚未招募
不适用
Clinical effect of lafutidine (Protecadin) on the mild case of Reflux Disease (health care economic comparison of which it contrasts Lansoprazole)reflux esophagitisJPRN-UMIN000006162PROMISE study Society160
已完成
2 期
The efficacy of lafutidine in patients with chemotherapy-induced peripheral neuropathy treated with a taxane.JPRN-UMIN000005338Yokohama City University30
已完成
3 期
The effect of Iberogast on heartburn in patients with functional dyspepsiaHeartburnpyrosis10017977NL-OMON49070Academisch Medisch Centrum18
进行中（未招募）
1 期
The effect of Iberogast on heartburn in patients with indigestion.Dyspepsia (according to the Rome III criteria) with heartburn.Upper gastro-intestinal causes of the complaints excluded via gastroscopyTherapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2016-003739-40-NLAMC Amsterdam18